Heart Foundation Commends Australian Parliament on New Tobacco Control Legislation

Regulations by 2FIRSTS.ai
Dec.11.2023
Heart Foundation Commends Australian Parliament on New Tobacco Control Legislation
Heart Foundation welcomes the Australian Parliament's passing of the 2023 Public Health (Tobacco and Other Products) Act, aimed at reducing harm from tobacco and nicotine addiction to heart health.

According to recent reports from Australian media outlet Miragenews, the Heart Foundation has expressed its satisfaction with the passing of the 2023 Public Health (Tobacco and Other Products) Bill by the Australian Parliament today.

 

This is a critical initiative aimed at preventing and further reducing the harm of tobacco and nicotine addiction on people's heart health. Both smoking and vaping pose significant risks to the cardiovascular health of Australian residents: smoking increases the risk of heart attack or stroke by four times, and the risk of sudden cardiac death by three times.

 

The latest research also reveals that the use of e-cigarettes can lead to an increase in tobacco smoking and elevate the risk of cardiovascular diseases. This further demonstrates the significance of these laws in combating smoking and nicotine addiction.

 

The Heart Research Foundation has praised the positive actions taken by the Australian Parliament today and congratulated Health Minister Mark Butler and his Australian government for their commitment to the health and well-being of all Australian residents.

 

This legislation has made significant improvements to tobacco control measures in Australia, including updating and enhancing graphic health warnings on packaging, incorporating health messaging into tobacco product packaging, ensuring e-cigarettes are also subject to advertising restrictions, limiting the use of attractive brand and variant names that imply reduced harm, aligning with many other countries worldwide by prohibiting the use of menthol in tobacco products, and introducing new reporting requirements for the tobacco industry, including reporting on ingredients used in tobacco products.

 

David Lloyd, CEO of the Heart Research Foundation, has praised the collaborative efforts of the Parliament and congratulated the Australian government on passing new tobacco control legislation. According to him, these new laws will play a crucial role in protecting a new generation of young Australians from lifelong heart health issues. He highlighted the progress made in the fight against smoking over the past few decades and emphasized the need for these regulations to continue mitigating the burden of disease and death caused by tobacco and nicotine products.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.